Citigroup’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-906,013
Closed -$3.81M 5099
2023
Q1
$3.81M Buy
906,013
+263,892
+41% +$1.11M ﹤0.01% 1230
2022
Q4
$3.86M Sell
642,121
-347,325
-35% -$2.09M ﹤0.01% 1172
2022
Q3
$5.76M Buy
989,446
+547,603
+124% +$3.19M ﹤0.01% 1053
2022
Q2
$2.64M Buy
441,843
+359,425
+436% +$2.15M ﹤0.01% 1419
2022
Q1
$385K Buy
+82,418
New +$385K ﹤0.01% 3014
2021
Q3
Sell
-3
Closed 5771
2021
Q2
$0 Sell
3
-26,560
-100% ﹤0.01% 5857
2021
Q1
$77K Buy
26,563
+2,419
+10% +$7.01K ﹤0.01% 3837
2020
Q4
$78K Buy
24,144
+24,141
+804,700% +$78K ﹤0.01% 3842
2020
Q3
$0 Hold
3
﹤0.01% 5289
2020
Q2
$0 Sell
3
-20
-87% ﹤0.01% 5319
2020
Q1
$0 Hold
23
﹤0.01% 5388
2019
Q4
$0 Sell
23
-5,761
-100% ﹤0.01% 5353
2019
Q3
$5K Sell
5,784
-1,950
-25% -$1.69K ﹤0.01% 4825
2019
Q2
$7K Sell
7,734
-6,136
-44% -$5.55K ﹤0.01% 4840
2019
Q1
$14K Buy
13,870
+292
+2% +$295 ﹤0.01% 4663
2018
Q4
$10K Sell
13,578
-1,848
-12% -$1.36K ﹤0.01% 4642
2018
Q3
$33K Buy
15,426
+7,961
+107% +$17K ﹤0.01% 4324
2018
Q2
$38K Buy
7,465
+7,339
+5,825% +$37.4K ﹤0.01% 4042
2018
Q1
$0 Buy
126
+20
+19% ﹤0.01% 5175
2017
Q4
$0 Sell
106
-20
-16% ﹤0.01% 5153
2017
Q3
$0 Hold
126
﹤0.01% 5088
2017
Q2
$0 Hold
126
﹤0.01% 5171
2017
Q1
$0 Sell
126
-1
-0.8% ﹤0.01% 5063
2016
Q4
$0 Hold
127
﹤0.01% 5124
2016
Q3
$0 Sell
127
-10
-7% ﹤0.01% 5176
2016
Q2
$0 Sell
137
-19,045
-99% ﹤0.01% 5689
2016
Q1
$102K Buy
19,182
+12,618
+192% +$67.1K ﹤0.01% 3930
2015
Q4
$80K Buy
6,564
+6,401
+3,927% +$78K ﹤0.01% 3747
2015
Q3
$2K Sell
163
-461
-74% -$5.66K ﹤0.01% 4966
2015
Q2
$12K Sell
624
-847
-58% -$16.3K ﹤0.01% 4525
2015
Q1
$27K Sell
1,471
-1,357
-48% -$24.9K ﹤0.01% 4245
2014
Q4
$67K Buy
2,828
+2,222
+367% +$52.6K ﹤0.01% 3906
2014
Q3
$15K Sell
606
-1,209
-67% -$29.9K ﹤0.01% 4439
2014
Q2
$52K Sell
1,815
-1,074
-37% -$30.8K ﹤0.01% 3539
2014
Q1
$98K Sell
2,889
-9,212
-76% -$312K ﹤0.01% 3510
2013
Q4
$233K Buy
12,101
+6,322
+109% +$122K ﹤0.01% 3023
2013
Q3
$95K Buy
5,779
+579
+11% +$9.52K ﹤0.01% 3178
2013
Q2
$55K Buy
+5,200
New +$55K ﹤0.01% 3720